b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="Publisher" Owner="NLM">\n        <PMID Version="1">32233709</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>02</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1476-4954</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Mar</Month>\n                        <Day>31</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title>\n                <ISOAbbreviation>J. Matern. Fetal. Neonatal. Med.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Selective intrauterine growth restriction (SIUGR) type II: proposed subclassification to guide surgical management.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>1-8</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2020.1745177</ELocationID>\n            <Abstract>\n                <AbstractText><b>Background:</b> Optimal surgical management of monochorionic diamniotic twins complicated by selective intrauterine growth restriction (SIUGR) type II is unknown. Surgical management may involve selective laser photocoagulation of communicating vessels (SLPCV), which offers the possibility of dual twin survivors versus umbilical cord occlusion (UCO) of the SIUGR twin.<b>Objective:</b> To identify patient characteristics associated with SIUGR twin survival for those undergoing SLPCV.<b>Study design:</b> All patients studied were those who underwent fetal treatment for SIUGR type II at our center from 2006-2018. SIUGR type II was defined as an estimated fetal weight &lt;10th percentile with persistent absent and/or reversed end diastolic flow in the umbilical artery of the SIUGR twin, in the absence of twin-twin transfusion syndrome. Patients were offered SLPCV versus UCO, and those undergoing SLPCV, patient characteristics associated with 30-day survival of the SIUGR twin were examined using bivariate analysis and multiple logistic regression models.<b>Results:</b> Fifty-four consecutive SIUGR type II patients were treated, 45 <i>via</i> SLPCV and nine <i>via</i> UCO. Of the 45 SLPCV cases, there were 16 (35.6%) with SIUGR twin (and dual) survival. SIUGR twin survival appeared associated with middle cerebral artery (MCA) peak systolic velocity (psv) &lt;1.5 multiples of the median, and forward atrial systolic flow in the ductus venosus (DV). In a <i>post hoc</i> analysis, we subsequently categorized patients as: SIUGR type IIa (<i>N</i>\xe2\x80\x89=\xe2\x80\x8932 (71.1%)): normal MCA psv, and normal DV waveform, versus SIUGR type IIb (<i>N</i>\xe2\x80\x89=\xe2\x80\x8913 (28.9%)): MCA psv \xe2\x89\xa51.5 multiples of the median, and/or DV with absent or reversed atrial systolic flow. Thirty-day survival of the SIUGR twin was 50% for type IIa and 0% for type IIb.<b>Conclusion:</b> Over one-third of SIUGR type II patients experienced dual survival after treatment with laser surgery. Normal MCA psv and normal DV waveforms were associated with SIUGR type II survival of the SIUGR twin. <i>Post hoc</i> exploration and subclassification of SIUGR type II patients by preoperative Doppler indices created two groups, one (type IIa) with 50% survival and one (type IIb) with 0% survival of the SIUGR twin after laser surgery. Upon further confirmation, these findings may provide guidance for counseling patients and conducting fetal therapy.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Chmait</LastName>\n                    <ForeName>Ramen H</ForeName>\n                    <Initials>RH</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4202-0259</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Pasadena, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Chon</LastName>\n                    <ForeName>Andrew H</ForeName>\n                    <Initials>AH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Pasadena, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Korst</LastName>\n                    <ForeName>Lisa M</ForeName>\n                    <Initials>LM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Childbirth Research Associates, North Hollywood, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Stephen</LastName>\n                    <ForeName>Y</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Pasadena, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Llanes</LastName>\n                    <ForeName>Arlyn</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Pasadena, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ouzounian</LastName>\n                    <ForeName>Joseph G</ForeName>\n                    <Initials>JG</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Pasadena, CA, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>03</Month>\n                <Day>31</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Matern Fetal Neonatal Med</MedlineTA>\n            <NlmUniqueID>101136916</NlmUniqueID>\n            <ISSNLinking>1476-4954</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Fetal growth restriction (FGR)</Keyword>\n            <Keyword MajorTopicYN="N">laser surgery</Keyword>\n            <Keyword MajorTopicYN="N">monochorionic twins</Keyword>\n            <Keyword MajorTopicYN="N">selective reduction</Keyword>\n            <Keyword MajorTopicYN="N">staging</Keyword>\n            <Keyword MajorTopicYN="N">twin growth discordance</Keyword>\n            <Keyword MajorTopicYN="N">umbilical cord occlusion</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>aheadofprint</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">32233709</ArticleId>\n            <ArticleId IdType="doi">10.1080/14767058.2020.1745177</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'